BridgeBio Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KOHLBERG KRAVIS ROBERTS & CO. L.P. | 02/14/2025 | 25.26 M | $693.16 M | 0.00% | 13.40% |
| VIKING GLOBAL INVESTORS LP | 02/14/2025 | 25.12 M | $689.32 M | 0.00% | 13.33% |
| VANGUARD GROUP INC | 02/11/2025 | 15.08 M | $413.74 M | 6.19% | 8.00% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 13.71 M | $376.19 M | 6.45% | 7.27% |
| STATE STREET CORP | 02/14/2025 | 6.18 M | $169.65 M | 3.69% | 3.28% |
| AISLING CAPITAL MANAGEMENT LP | 02/12/2025 | 6.07 M | $166.51 M | 0.00% | 3.22% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 4.91 M | $134.67 M | 1.86% | 2.60% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 4.20 M | $115.11 M | 140.13% | 2.23% |
| UBS GROUP AG | 02/14/2025 | 4.00 M | $109.81 M | -2.62% | 2.12% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 3.80 M | $104.28 M | 1.06% | 2.02% |
| LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 3.74 M | $102.65 M | -3.94% | 1.98% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/13/2025 | 3.53 M | $96.77 M | 34.90% | 1.87% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 3.51 M | $96.19 M | 11.71% | 1.86% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.42 M | $93.80 M | 0.11% | 1.81% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 2.79 M | $76.68 M | -1.18% | 1.48% |
| WOODLINE PARTNERS LP | 02/14/2025 | 2.21 M | $60.68 M | 132.85% | 1.17% |
| JANE STREET GROUP, LLC | 02/14/2025 | 2.18 M | $59.86 M | 9.20% | 1.16% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.04 M | $55.85 M | -0.82% | 1.08% |
| ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 1.98 M | $54.20 M | 4.75% | 1.05% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 1.89 M | $51.75 M | 23.08% | 1.00% |
| SC US (TTGP), LTD. | 02/14/2025 | 1.86 M | $51.05 M | 0.00% | 0.99% |
| UBS GROUP AG | 02/14/2025 | 1.84 M | $50.49 M | 69.29% | 0.98% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.81 M | $49.60 M | -35.52% | 0.96% |
| FMR LLC | 02/13/2025 | 1.62 M | $44.50 M | -10.92% | 0.86% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 1.60 M | $43.90 M | -13.90% | 0.85% |
| CITIGROUP INC | 02/12/2025 | 1.54 M | $42.22 M | 0.06% | 0.82% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.31 M | $35.86 M | 1.71% | 0.69% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.22 M | $33.59 M | 71.19% | 0.65% |
| EMERALD ADVISERS, LLC | 02/11/2025 | 1.15 M | $31.58 M | 4.29% | 0.61% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 02/14/2025 | 1.08 M | $29.52 M | 113.82% | 0.57% |
| NORGES BANK | 02/12/2025 | 1.07 M | $29.24 M | 100.00% | 0.57% |
| PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 1.05 M | $28.82 M | -8.29% | 0.56% |
| HHLR ADVISORS, LTD. | 02/14/2025 | 1.02 M | $28.10 M | 0.00% | 0.54% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 1.02 M | $27.87 M | 9.59% | 0.54% |
| PROSIGHT MANAGEMENT, LP | 02/14/2025 | 995,000 | $27.30 M | -8.45% | 0.53% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 991,238 | $27.20 M | 22.30% | 0.53% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 940,415 | $25.80 M | 100.00% | 0.50% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/10/2025 | 915,500 | $25.12 M | 0.97% | 0.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 905,279 | $24.84 M | 7.43% | 0.48% |
| 02/14/2025 | 898,458 | $24.65 M | 100.00% | 0.48% | |
| INVESCO LTD. | 02/13/2025 | 893,127 | $24.51 M | 4.16% | 0.47% |
| MARSHALL WACE, LLP | 02/13/2025 | 827,958 | $22.72 M | -0.63% | 0.44% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 819,162 | $22.48 M | 100.00% | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 02/14/2025 | 724,872 | $19.89 M | -3.52% | 0.38% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 700,000 | $19.21 M | 100.00% | 0.37% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 698,900 | $19.18 M | 2.58% | 0.37% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 678,857 | $18.63 M | -53.13% | 0.36% |
| JANE STREET GROUP, LLC | 02/14/2025 | 664,924 | $18.25 M | 26.81% | 0.35% |
| ARISTEIA CAPITAL LLC | 02/14/2025 | 661,000 | $18.14 M | 100.00% | 0.35% |
| 683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 635,000 | $17.42 M | 15.45% | 0.34% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BridgeBio Pharma, Inc. institutional Ownership - FAQ's
During the previous two years, 326 institutional investors and hedge funds held shares of BridgeBio Pharma, Inc.. The most heavily invested institutionals were:
Kohlberg Kravis Roberts & Co. L.P.: 25.26 M
VIKING GLOBAL INVESTORS LP: 25.12 M
VANGUARD GROUP INC: 15.08 M
BlackRock Funding, Inc. /DE: 13.71 M
STATE STREET CORP: 6.18 M
Aisling Capital Management LP: 6.07 M
93.73% of BridgeBio Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 195.99 M shares in the last 24 months. This purchase volume represents approximately $5.54 B in transactions.